Management of bleeding and procedures in patients on antiplatelet therapy

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Antiplatelet medications are crucial for secondary prevention in cardiovascular disease.
• Potent antiplatelet agents are increasingly used with coronary stents to prevent occlusion.
• These antithrombotic drugs carry a risk of serious bleeding, including intracranial and gastrointestinal hemorrhage.

Purpose of the Study:

• To provide updated guidance on managing bleeding in patients on antiplatelet therapy.
• To offer evidence-based recommendations for urgent surgery in patients receiving antiplatelet medications.
• To highlight the need for further research to develop robust clinical guidelines.

Main Methods:

• Review of recent studies and clinical guidelines.
• Synthesis of current evidence on managing bleeding complications.
• Analysis of strategies for perioperative management in patients on antiplatelet drugs.

Main Results:

• Significant bleeding risks associated with potent antiplatelet agents, especially post-stenting.
• Lack of comprehensive guidelines for managing bleeding and urgent surgery.
• Emerging data offers some insights but further evidence is required.

Conclusions:

• Updated guidance is provided for managing bleeding and urgent surgery in patients on antiplatelet drugs.
• Current evidence is limited, necessitating cautious clinical decision-making.
• Further research is essential to establish evidence-based guidelines for these scenarios.